Search

Fazel, Reza, Sunil Rao V, David J Cohen, Eric A Secemsky, Rajesh Swaminathan V, Pratik Manandhar, Jennifer A Rymer, Daniel M Wojdyla, and Robert W Yeh. 2025. “Radial Vs Femoral Access for Percutaneous Coronary Intervention: Temporal Trends and Outcomes in the USA.”. European Heart Journal.

Sammour, Yasser M, Safi U Khan, Haoyun Hong, Jingyuan Wu, Alexander C Fanaroff, Grant W Reed, Remy Poudel, et al. 2025. “Institutional Variability in Processes of Care and Outcomes Among Patients With STEMI in the US.”. JAMA Cardiology 10 (8): 787-96.

Liu, Michael, and Rishi K Wadhera. 2025. “High-Risk Areas-The Trees in the Forest-Reply.”. JAMA Cardiology.

Liu, Michael, and Rishi K Wadhera. 2025. “The United States Faces a Healthcare Affordability Crisis.”. BMJ (Clinical Research Ed.) 390: r1702.

Inoue, Kosuke, Michael Liu, and Rishi K Wadhera. 2025. “Prevalence and Control of Diabetes Among US Adults-Reply.”. JAMA 334 (5): 453-54.

Liu, Michael, Daniel Y Johnson, Sara N Bleich, Prihatha R Narasimmaraj, Camilla Bjorck-Posson, Jose F Figueroa, and Rishi K Wadhera. 2025. “Changes in Physical and Mental Health After the End of SNAP Emergency Allotments.”. JAMA 334 (2): 175-77.

Inoue, Kosuke, Dhruv S Kazi, Muthiah Vaduganathan, and Rishi K Wadhera. 2025. “Prescription Patterns for GLP-1 Receptor Agonists and SGLT2 Inhibitors by Physicians’ Years in Practice.”. Journal of General Internal Medicine 40 (11): 2807-9.

King, Sara J, Tenzin Yeshi Wangdak Yuthok, Adrian M Bacong, Abha Khandelwal, Dhruv S Kazi, Michael E Mussolino, Sally S Wong, et al. 2025. “Heart Disease Mortality in the United States, 1970 to 2022.”. Journal of the American Heart Association 14 (13): e038644.

Shi, Ivy, Sadiya S Khan, and Dhruv S Kazi. 2025. “The Limitations and Risks Associated With Semaglutide Treatment-Reply.”. JAMA Cardiology 10 (7): 749.

DeJong, Colette, Kosuke Inoue, Matthew S Durstenfeld, Anubha Agarwal, Justin C Chen, Chien-Wen Tseng, Adams Dudley, Priscilla Y Hsue, and Dhruv S Kazi. 2025. “Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy for Heart Failure With Reduced Ejection Fraction.”. JACC. Heart Failure 13 (7): 102380.